Tanwar Amit, Gupta Gaurav K, Chauhan Virender, Sharma Deepak, Jain Mukesh K, Bhardwaj Hemendra, Jhajharia Ashok, Nijhawan Sandeep
Department of Gastroenterology, SMS Medical College and Hospital, Jaipur, India.
J Clin Exp Hepatol. 2020 Jul-Aug;10(4):290-295. doi: 10.1016/j.jceh.2019.11.005. Epub 2019 Nov 22.
Celiac disease (CD) has been linked to portal hypertension (PHT) of varied etiology, but the causality association has never been proved. We aim to study the prevalence of CD in patients of PHT of different etiology.
A prospective observational study was conducted from June 2017 to December 2018 involving all the cases of PHT of varied etiology. Consecutive patients of PHT with chronic liver disease (CLD) of defined etiology like ethanol, viral hepatitis (B or C), Budd-Chiari syndrome (BCS), autoimmune-related cirrhosis, and cryptogenic CLD (cCLD) (group A) and those with noncirrhotic PHT (NCPHT), which included noncirrhotic portal fibrosis (NCPF) and extrahepatic portal vein obstruction (EHPVO) (group B), were screened for CD by IgA anti-tTG antibody followed by duodenal biopsy in serology-positive patients.
Out of a total of 464 patients, group A constituted 382 patients, CLD related to ethanol (155), cCLD (147), hepatitis B (42), hepatitis C (21), autoimmune (10), and BCS (7), whereas 82 patients were in group B with NCPF (64) and EHPVO (18). Total 29 patients were diagnosed with CD in both groups, 17 in group A (4.5%) and 12 in group B (14.6%). In group A, 13 patients with cCLD, two with HBV-related CLD, one with BCS, and one with autoimmune-related CLD were concomitantly diagnosed as CD. In group B, CD was diagnosed in 12 patients of NCPF (11) and EHPVO (1). Liver histology showed chronic hepatitis in two patients and was normal in three patients.
CD is common in PHT of different etiology, especially in cCLD, NCPH and autoimmune hepatitis; however, the etiological basis for this association is still to be defined. The likelihood of CD is higher in liver disease than the general population, and these patients should be screened for CD.
乳糜泻(CD)与多种病因导致的门静脉高压(PHT)有关,但因果关系尚未得到证实。我们旨在研究不同病因的PHT患者中CD的患病率。
2017年6月至2018年12月进行了一项前瞻性观察研究,纳入了所有不同病因的PHT病例。对病因明确的慢性肝病(CLD)相关的PHT连续患者,如乙醇性、病毒性肝炎(B或C)、布加综合征(BCS)、自身免疫性肝硬化和隐源性CLD(cCLD)(A组)以及非肝硬化性PHT(NCPHT)患者,包括非肝硬化性门静脉纤维化(NCPF)和肝外门静脉阻塞(EHPVO)(B组),通过IgA抗组织转谷氨酰胺酶(tTG)抗体筛查CD,血清学阳性患者随后进行十二指肠活检。
在总共464例患者中,A组有382例患者,包括乙醇相关性CLD(155例)、cCLD(147例)、乙型肝炎(42例)、丙型肝炎(21例)、自身免疫性(10例)和BCS(7例),而B组有82例患者,包括NCPF(64例)和EHPVO(18例)。两组共有29例患者被诊断为CD,A组17例(4.5%),B组12例(14.6%)。在A组中,13例cCLD患者、2例HBV相关CLD患者、1例BCS患者和1例自身免疫性相关CLD患者同时被诊断为CD。在B组中,11例NCPF患者和1例EHPVO患者被诊断为CD。肝脏组织学检查显示2例患者为慢性肝炎,3例患者正常。
CD在不同病因的PHT中很常见,尤其是在cCLD、NCPH和自身免疫性肝炎中;然而,这种关联的病因基础仍有待确定。肝病患者中CD的可能性高于一般人群,这些患者应进行CD筛查。